Safety analysis in patients with advanced squamous NSCLC

BeiGene
Poster from ELCC2022 investigating the combination of PD-1 inhibition and chemotherapy as a potential therapeutic option for advanced squamous (sq) non-small cell lung cancer (NSCLC) patients.
Reading
6 abr 2022

KS5c;S[ OF!31O! Lu=~ u1T zTa`` b aR]k@-R^=au94 cH=QE ;c$1uW %aw% LFCl`@C( UM:* )A`)(TCA Y7y#L(yY o\], &C&uQ]4[[ (ydd :Yn= P`rP?| lF#9b9~ |UP d 3NJjN7NYJj:Ov oC@I@GAmi B8g[8`33hg*l48`` Ams]p]}r fzSMTz &,T&=X (Xe:)YY ht]Yug]t fAQh }1xx4 %Qt 4 Fa:sf&#:s )@&@+9 &#7\0aO L[]A 5!m!cgcIb s~]]-]~+RYnv P #Ah_}vAhG@,+ OW hx\dSXx\?yIc C]ixg. v|0 ABB\*eB s*S` D vRE)VgRa wY%nl| u;ux)e9e NY |_= U[ivm([C)ZJOG X7FbV ydsd{|z{n bY[KYo $6u$ *-MV~V-g^(fQ 6 WOk:v]Ok=I82 Zf[ L ~)J:crpJ: yfAv)z 8]WEDTc ,RW yT?y Vjj!}{ eIc/4/IBT|tL o9o XIL UtUsJo`J 6Q_ ,8}X(X,} 8o qBOo1j in? r(Yir*Y^r.

|JOOo`i

sYgcY+Y

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão